Together we will beat cancerDonate
Cervical cancer is more common in younger women, with around 3,200 people diagnosed in the UK each year. It develops in the lining of the cervix – the lower part of the womb – and the main symptom is unusual or unexplained vaginal bleeding.
Cervical cancer rates are predicted to fall following the introduction of HPV primary screening this year.
A new cervical cancer test is big news this week. The science behind the headlines is exciting, but it’s a long way from being used in cervical screening.
Cervical screening could be stopped at the age of 55 for some women if the HPV test is used first, according to a new computer simulation study.
A vaccine to prevent cervical cancer is safe and effective in reducing cell changes, a new review has confirmed.
New research shows women who have had the HPV vaccine may only need 3 cervical screens in their entire life, rather than the 12 that are standard in the UK.
Less than three quarters of eligible women are attending cervical cancer screening appointments in England, according to new figures.
Women may only need three cervical screens in their lifetime if they have been given the human papillomavirus (HPV) vaccine.
More than a quarter (28 per cent) of women who are overdue for a smear test don’t know about the cervical screening programme.
In the second part of our World Cancer Day series, we take a look at cervical cancer rates in different parts of the world. Read on to find out what can be done to prevent the disease in the future.
A large analysis of cervical tumour samples has found distinct genetic ‘signatures’ that could better define the disease.